Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: HMRC's new tax deals, Tesco's debt, Sainsbury's

Sun, 24th Jan 2016 16:11

(ShareCast News) - In the wake of Google's £130m tax settlement with the UK taxman, other giant US corporations are close to shaking hands on their own deals. HM Revenue & Customs officials have confirmed to the Sunday Times that Amazon, Facebook, Microsoft and McDonald's are all close to agreements that would swell the national coffers but are likely to land the office in hot water after Google was felt to have got of lightly.Ahead of looming lending deadlines, Tesco has begun working on restructuring £1.4bn of its £17.5bn debt mountain. The grocer aims to repay £1.4bn in the next few months, the Sunday Telegraph said, as the risk of default on its borrowings climbed to the highest on record.With its own deadline of 2 February, Sainsbury's is under pressure from major investors to up its bid for Argos owner Home Retail but not over-pay for the deal. With Home Retail shareholders wanting around 220p a share, Sainsbury's management have been frustrated in their efforts to drum up support from their own backers due to wildly different views on valuation, according to sources cited by the Sunday Telegraph.Meanwhile, some of the pressure has dissipated in Shell's £36bn takeover of BG Group after news that a Brazil no longer plans to hike taxes on the oil sector. Fear of such a hike had led some institutional investors to plan to vote against the deal this Thursday, the Mail on Sunday reported.Activist investor Och-Ziff Capital has taken a stake in GlaxoSmithKline and is understood to have been adding to the heat on the drug group to replace chief executive Andrew Witty. The Sunday Times reported that the Manhattan firm's London arm has spoken to GS chairman Sir Philip Hampton, adding to pressure on Witty and finance director Simon Dingemans.The current state of high street banking IT systems is not up to scratch and the chief executives of Royal Bank of Scotland, HSBC and Barclays, as well as the heads of the Bank of England's regulatory arms, have been told to urgently begin addressing the matter from board level downwards. MP Andrew Tyrie, chairman of the Commons' Treasury Committee, said Andrew Bailey, Deputy Governor of the Bank of England and chief executive the bank's Prudential Regulation Authority (PRA) should lead official efforts to enforce banks to bring their computer systems up to scratch, the Sunday Times reported.Standard Chartered has found it difficult to find a suitable person to replace Sir John Peace as chairman. Major shareholders, cited by the Sunday Times, admitted the "modest salary" was a problem as "very few people who would take on the risk of being the chairman of a bank these days", heightened by regulations intended to make executives more accountable for scandals.Deutsche Bank may need to raise cash through a bond sale, or sale of its Postbank subsidiary, after analysts identified a €7bn capital hole in its accounts that will need to be filled by the end of next year. The lender's new chief executive, John Cryan, is looking to conserve cash by stopping the bank's dividend for the next two years, the Sunday Times said.Elsewhere in the banking sector, a pair of banks from Iran are in talks with UK regulators about reopening their doors to British businesses after lifting of sanctions against the Middle Eastern country, the Sunday Times revealed. Melli Bank and Persia International Bank have been given their license back by the Bank of England, while international banks around the world are preparing to re-establish links with Iranian counterparts using the Swift payments system.Profit warnings have soared to a post-crisis peak, according to figures compiled by Ernst & Young cited by the Sunday Telegraph. Data showed UK-listed companies have issued 313 downgrades over the past year, the most since 2008.Online grocer Ocado has attracted even more interest from short-selling hedge funds. Now the second most shorted company in the FTSE 350, Ocado's share price tumble was arrested by rumours of a takeover bid from online giant Amazon, but this has only served to dramatically increase short interest in the last week, said the Mail on Sunday.Imagination Technologies is poised to begin a major restructuring, including radical cost-cutting and the sale of its Pure digital radio arm. After a round of crisis talks with top institutional shareholders, chairman Bert Nordberg revealed plans to dispose of loss-making divisions as well as the possible sale of its corporate headquarters, the Sunday Times reported.Metro Bank will join its fellow UK challenger banks on the public markets with a £2bn initial public offer that flies in the face of the month's stock market turmoil. Metro, which in 2010 became the first new bank to launch in Britain for more than 100 years, has drawn up plans with its advisers to float £300m of its shares, the Mail on Sunday said, with a formal intention-to-float document expected this week.Mountain Warehouse could join it with its own £200m flotation, according to the Sunday Times. The retailer, which would be the first to IPO in London for almost a year, has appointed Rothschild to examine the move.Watkins Jones, the Welsh building and property management firm, has also begun working on a flotation with advisers at Zeus Capital. The company, which has an impressive client list and specialises in building student halls of residence, could be worth up to £300m, the Sunday Times said.
More News
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.